Search Results

Breast Cancer Chemoprevention: Current Perspectives

Authors: Oyama, Takeru; Yasui, Yumiko; Tanaka, Takuji

Source: Current Enzyme Inhibition, Volume 5, Number 4, December 2009 , pp. 198-208(11)

Publisher: Bentham Science Publishers

Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay

Authors: Stevenson, Susan; Sharpe, David T.; Julie Thornton, M.

Source: Experimental Dermatology, Volume 18, Number 11, November 2009 , pp. 988-990(3)

Publisher: Blackwell Publishing

Osteoporosis management among residents living in long-term care

Authors: Giangregorio, L.; Jantzi, M.; Papaioannou, A.; Hirdes, J.; Maxwell, C.; Poss, J.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1471-1478(8)

Publisher: Springer

Bisphosphonates look best for osteoporosis in Thai women

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 5-5(1)

Publisher: Adis International

First analysis of pharma uptake after NICE approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 5-5(1)

Publisher: Adis International

Although tamoxifen, raloxifene and tibolone significantly reduce the risk of breast cancer, the use of each drug is associated with distinct adverse effects

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 3-3(1)

Publisher: Adis International

Oestradiol and SERM treatments influence oestrogen receptor coregulator gene expression in human skeletal muscle cells

Authors: Dieli-Conwright, C. M.; Spektor, T. M.; Rice, J. C.; Todd Schroeder, E.

Source: Acta Physiologica, Volume 197, Number 3, November 2009 , pp. 187-196(10)

Publisher: Blackwell Publishing

Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer

Authors: Wang, Tianlin; You, Qidong; Huang, Frank S.h.u-g.u.i.; Xiang, Hua

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 10, September 2009 , pp. 1191-1201(11)

Publisher: Bentham Science Publishers

Effects of raloxifene on the mammary epithelium of female rats in persistent estrus

Authors: Nogueira, Ludmila; da Silva, Benedito

Source: Gynecological Endocrinology, Volume 25, Number 6, June 2009 , pp. 357-361(5)

Publisher: Informa Healthcare

Effects of zearalenone and α-Zearalenol in comparison with Raloxifene on T47D cells

Authors: Khosrokhavar, Roya; Rahimifard, Nahid; Shoeibi, Shahram; Hamedani, Morteza Pirali; Hosseini, Mir-Jamal

Source: Toxicology Mechanisms and Methods, Volume 19, Number 3, March 2009 , pp. 246-250(5)

Publisher: Informa Healthcare

New ASCO drug guidelines for breast cancer risk reduction

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 580, 2009-06-13 , pp. 3-3(1)

Publisher: Adis International

Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women

Authors: da Silva, B. B.; dos Santos, A. R.; Pires, C. G.; Lopes-Costa, P. V.

Source: Cell Proliferation, Volume 42, Number 4, August 2009 , pp. 506-510(5)

Publisher: Blackwell Publishing

Individualized therapy for osteoporosis prevention and treatment in women under 60

Author: de Villiers, T. J.

Source: Climacteric, Volume 12, Number 3, June 2009 , pp. 210-212(3)

Publisher: Informa Healthcare

Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

Authors: Peng, Jing; Sengupta, Surojeet; Jordan, V. C.

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 5, June 2009 , pp. 481-499(19)

Publisher: Bentham Science Publishers

The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis

Authors: Maximov, Philipp Y.; Lewis-Wambi, Joan S.; Jordan, Virgil C.

Source: Current Signal Transduction Therapy, Volume 4, Number 2, May 2009 , pp. 88-102(15)

Publisher: Bentham Science Publishers

Raloxifene: First report of acceleration of platelet aggregation: case report

Source: Reactions, Volume 1, Number 1250, 2009-05-02 , pp. 34-34(1)

Publisher: Adis International

Solid State Interaction of Raloxifene HCl with Different Hydrophilic Carriers During Co-grinding and its Effect on Dissolution Rate

Authors: Garg, Anuj; Singh, S.; Rao, V. U.; Bindu, K.; Balasubramaniam, J.

Source: Drug Development and Industrial Pharmacy, Volume 35, Number 4, April 2009 , pp. 455-470(16)

Publisher: Informa Healthcare

Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk

Authors: Cummings, Steven R.; Tice, Jeffrey A.; Bauer, Scott; Browner, Warren S.; Cuzick, Jack; Ziv, Elad; Vogel, Victor; Shepherd, John; Vachon, Celine; Smith-Bindman, Rebecca; Kerlikowske, Karla

Source: Journal of the National Cancer Institute, Volume 101, Number 6, 18 March 2009 , pp. 384-398(15)

Publisher: Oxford University Press

Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics

Authors: Trontelj, Jurij; Marc, Janja; Zavratnik, Andrej; Bogataj, Marija; Mrhar, Aleš

Source: British Journal of Clinical Pharmacology, Volume 67, Number 4, April 2009 , pp. 437-444(8)

Publisher: Blackwell Publishing

Tamoxifen, raloxifene worthwhile for high breast-cancer risk

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 573, 2009-03-07 , pp. 6-6(1)

Publisher: Adis International